India's Shalby gains on US FDA approval for knee replacement device

Shalby

16/01/2025 04:31

** Shares of hospital chain operator Shalby  SHAY.NS 
rise as much as 4.9% to 233.65 rupees; currently up 2.6%
    ** Co on Wednesday said its U.S. unit received U.S. FDA
clearance for DuraniomTM, its primary total knee replacement
device
    ** Stock on track for a third consecutive session of gains,
if trend holds
    ** SHAY fell 24.1% in 2024, snapping four straight years of
gains
     
     
     

(Reporting by Ashish Chandra in Bengaluru)
((mailto:ashish.chandra@thomsonreuters.com (+91 7982114624))